News Articles and Montana BioScience Alliance Newsletters

MONTANA BIOSCIENCE ENTERPRISES IN THE NEWS

At first glance, a room in the basement of McGill Hall on the University of Montana campus appears like a private gym with treadmills, dumbbells and exercise bikes.  It seems like a good place for a workout. But the space is actually a research laboratory for students and faculty in UM’s School of Integrative Physiology and Athletic Training within the College of Health. 

University of Montana
|
March 20, 2024

Doug Brinkerhoff intends to use computer deep learning to improve predictions of sea level rise from melting ice sheets. Beverly Piggott will study how brain cells regulate their own acidity during development.

A team of scientists from Montana State University recently published unique research examining how individual cells respond to viral infection. The work used state-of-the-art technology to culture cells and track infection in real time; it is the first known project to use microfluidic technology to culture, infect and track infection on a single-cell level. 

A Montana State University researcher was recently awarded a $2.76 million, five-year grant from the National Institutes of Health to help find pre-symptom evidence of the onset of osteoarthritis, a disease that affects one in seven Americans. 

Wintermute Biomedical has successfully raised USD 1.3 million from investors to propel its groundbreaking Shingles treatment, Solexan™, into a Phase Ib clinical trial. The primary focus of this randomized double-blind placebo-controlled trial is to assess the safety, tolerability, and proof-of-concept efficacy of Solexan™ in reducing shingles-related pain and expediting lesion healing.

ARTICLES OF INTEREST

Bio
|
December 11, 2023

The wait is finally over as the Biotechnology Innovation Organization (BIO) taps John F. Crowley, a longtime leader and tireless patient advocate in the biotech industry, to fill the role of the organization’s new CEO.

Vertex Pharmaceuticals and bluebird bio
|
December 11, 2023

Dec. 8 was a historic day for the sickle cell community and CRISPR technology, as the U.S. Food and Drug Administration (FDA) approved two milestone treatments: Casgevy, made by Vertex Pharmaceuticals, and Lyfgenia, made by bluebird bio.

National Institute on Aging
|
November 12, 2023

The NIA is accepting applications for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding. Learn more about these open opportunities. The next deadline to apply is January 5, 2024, unless otherwise noted. 

National Institutes of Health
|
November 12, 2023

The Senate has voted to confirm President Joe Biden’s pick to run the National Institutes of Health (NIH), Dr. Monica Bertagnolli, filling the director spot at the country’s top medical research agency after a vacancy of almost two years.

National Institutes of Health
|
October 8, 2023

Updates from product development and small business programs

NEWSLETTER

Newsletter
|
February 20, 2024

View the Winter II 2024 Newsletter now!

Newsletter
|
December 21, 2023

View the Winter 2023 Newsletter now!